H1-0 and cancer: Intriguingly, ELANE can not only selectively induce cell death in diverse cancer cells, but not in normal cells, through liberating the CD95 death domain (DD) that interacts with histone H1 isoforms, but also prevent distant metastasis through triggering an abscopal effect mediated by CD8+ T cells.